Mountain Valley MD (CSE: MVMD) Director of Life Sciences Mike Farber joined Steve Darling from Proactive with news the company has applied for a patent to cover a novel dose sparing adjuvant with a potential application for Polio IPV delivery and the broader category of vaccines.
Farber gives detail about what that patent covers and also what the next steps will be for testing and verification.